(Q60895640)
Statements
The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients (English)
Susanna Leskelä
Iván Muñoz
Andrés Redondo
Javier de Santiago
21 December 2010